These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 32123189)

  • 1. Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31.
    Pothineni VR; Potula HSK; Ambati A; Mallajosyula VVA; Sridharan B; Inayathullah M; Ahmed MS; Rajadas J
    Sci Rep; 2020 Mar; 10(1):3798. PubMed ID: 32123189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells.
    Sharma B; Brown AV; Matluck NE; Hu LT; Lewis K
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4616-24. PubMed ID: 26014929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stationary phase persister/biofilm microcolony of Borrelia burgdorferi causes more severe disease in a mouse model of Lyme arthritis: implications for understanding persistence, Post-treatment Lyme Disease Syndrome (PTLDS), and treatment failure.
    Feng J; Li T; Yee R; Yuan Y; Bai C; Cai M; Shi W; Embers M; Brayton C; Saeki H; Gabrielson K; Zhang Y
    Discov Med; 2019 Mar; 27(148):125-138. PubMed ID: 30946803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying Vancomycin as an Effective Antibiotic for Killing Borrelia burgdorferi.
    Wu X; Sharma B; Niles S; O'Connor K; Schilling R; Matluck N; D'Onofrio A; Hu LT; Lewis K
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126963
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline.
    Feng J; Auwaerter PG; Zhang Y
    PLoS One; 2015; 10(3):e0117207. PubMed ID: 25806811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eradication of Biofilm-Like Microcolony Structures of Borrelia burgdorferi by Daunomycin and Daptomycin but not Mitomycin C in Combination with Doxycycline and Cefuroxime.
    Feng J; Weitner M; Shi W; Zhang S; Zhang Y
    Front Microbiol; 2016; 7():62. PubMed ID: 26903956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of new compounds with high activity against stationary phase Borrelia burgdorferi from the NCI compound collection.
    Feng J; Shi W; Zhang S; Zhang Y
    Emerg Microbes Infect; 2015 Jun; 4(6):e31. PubMed ID: 26954881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo evaluation of cephalosporins for the treatment of Lyme disease.
    Pothineni VR; Parekh MB; Babar MM; Ambati A; Maguire P; Inayathullah M; Kim KM; Tayebi L; Potula HS; Rajadas J
    Drug Des Devel Ther; 2018; 12():2915-2921. PubMed ID: 30254421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generality of Post-Antimicrobial Treatment Persistence of
    Hodzic E; Imai DM; Escobar E
    Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31308087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidases from Borrelia burgdorferi: Antibiotic targets for Lyme disease.
    Cornell KA; Knippel RJ; Cortright GR; Fonken M; Guerrero C; Hall AR; Mitchell KA; Thurston JH; Erstad P; Tao A; Xu D; Parveen N
    Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129455. PubMed ID: 31669585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection.
    Embers ME; Barthold SW; Borda JT; Bowers L; Doyle L; Hodzic E; Jacobs MB; Hasenkampf NR; Martin DS; Narasimhan S; Phillippi-Falkenstein KM; Purcell JE; Ratterree MS; Philipp MT
    PLoS One; 2012; 7(1):e29914. PubMed ID: 22253822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coinfection with Borrelia burgdorferi sensu stricto and Borrelia garinii alters the course of murine Lyme borreliosis.
    Hovius JW; Li X; Ramamoorthi N; van Dam AP; Barthold SW; van der Poll T; Speelman P; Fikrig E
    FEMS Immunol Med Microbiol; 2007 Mar; 49(2):224-34. PubMed ID: 17328756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftriaxone Pulse Dosing Fails to Eradicate Biofilm-Like Microcolony
    Feng J; Zhang S; Shi W; Zhang Y
    Front Microbiol; 2016; 7():1744. PubMed ID: 27867375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forty Years of Evidence on the Efficacy and Safety of Oral and Injectable Antibiotics for Treating Lyme Disease of Adults and Children: A Network Meta-Analysis.
    Yang J; Wen S; Kong J; Yue P; Cao W; Xu X; Zhang Y; Chen J; Liu M; Fan Y; Luo L; Chen T; Li L; Li B; Dong Y; Luo S; Zhou G; Liu A; Bao F
    Microbiol Spectr; 2021 Dec; 9(3):e0076121. PubMed ID: 34756070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A doxycycline hyclate rodent bait formulation for prophylaxis and treatment of tick-transmitted Borrelia burgdorferi.
    Dolan MC; Zeidner NS; Gabitzsch E; Dietrich G; Borchert JN; Poché RM; Piesman J
    Am J Trop Med Hyg; 2008 May; 78(5):803-5. PubMed ID: 18458316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor necrosis factor-alpha treatment activates Borrelia burgdorferi spirochetes 4 weeks after ceftriaxone treatment in C3H/He mice.
    Yrjänäinen H; Hytönen J; Song XY; Oksi J; Hartiala K; Viljanen MK
    J Infect Dis; 2007 May; 195(10):1489-96. PubMed ID: 17436229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of Borrelia burgdorferi isolates to three antibiotics commonly used for treating equine Lyme disease.
    Caol S; Divers T; Crisman M; Chang YF
    BMC Vet Res; 2017 Sep; 13(1):293. PubMed ID: 28962614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resurgence of persisting non-cultivable Borrelia burgdorferi following antibiotic treatment in mice.
    Hodzic E; Imai D; Feng S; Barthold SW
    PLoS One; 2014; 9(1):e86907. PubMed ID: 24466286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of Sulfa Drugs and Their Combinations against Stationary Phase B. burgdorferi In Vitro.
    Feng J; Zhang S; Shi W; Zhang Y
    Antibiotics (Basel); 2017 Mar; 6(1):. PubMed ID: 28327498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis.
    Preac Mursic V; Marget W; Busch U; Pleterski Rigler D; Hagl S
    Infection; 1996; 24(1):9-16. PubMed ID: 8852456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.